# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-23-099889
Filing Date
2023-12-29
Accepted
2023-12-29 16:05:44
Documents
64
Period of Report
2023-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ANNUAL REPORT | f10k2023_citiuspharma.htm iXBRL | 10-K | 1547565
2 | FORM OF COMMON STOCK PURCHASE WARRANT, DATED AUGUST 13, 2018, AS AMENDED AUGUST | f10k2023ex4-1_citiuspharma.htm | EX-4.1 | 101388
3 | FORM OF UNDERWRITER'S COMMON STOCK PURCHASE WARRANT, DATED AUGUST 13, 2018, AS A | f10k2023ex4-3_citiuspharma.htm | EX-4.3 | 104009
4 | SUBSIDIARIES | f10k2023ex21_citiuspharma.htm | EX-21 | 2698
5 | CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM | f10k2023ex23-1_citiuspharma.htm | EX-23.1 | 1968
6 | CERTIFICATION | f10k2023ex31-1_citiuspharma.htm | EX-31.1 | 11328
7 | CERTIFICATION | f10k2023ex31-2_citiuspharma.htm | EX-31.2 | 11176
8 | CERTIFICATION | f10k2023ex32-1_citiuspharma.htm | EX-32.1 | 5890
| Complete submission text file | 0001213900-23-099889.txt |  | 5675538

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL SCHEMA FILE | ctxr-20230930.xsd | EX-101.SCH | 54762
10 | XBRL CALCULATION FILE | ctxr-20230930_cal.xml | EX-101.CAL | 30309
11 | XBRL DEFINITION FILE | ctxr-20230930_def.xml | EX-101.DEF | 211189
12 | XBRL LABEL FILE | ctxr-20230930_lab.xml | EX-101.LAB | 453906
13 | XBRL PRESENTATION FILE | ctxr-20230930_pre.xml | EX-101.PRE | 223447
58 | EXTRACTED XBRL INSTANCE DOCUMENT | f10k2023_citiuspharma_htm.xml | XML | 495104

Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 001-38174 | Film No.: 231527682
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)